We are delighted and honoured that Callavid® has been named in this National Institute for Health and Care Research (NIHR) news story highlighting the role NIHR is playing in improving outcomes for women through the UK Government’s revised Women’s Health Strategy. 🇬🇧 As NIHR notes: “NIHR is funding ‘Callavid’ which if approved would be the …

original article here: https://drug-dev.com/expert-content/the-most-underutilized-route-in-drug-delivery-how-vaginal-therapeutics-are-finally-getting-the-platform-they-deserve/ The Most Underutilized Route in Drug Delivery: How Vaginal Therapeutics Are Finally Getting the Platform They Deserve By: Lara Zibners, MD, MMEd, MBA Women are: 51% of the population The majority of prescription drug users (QuickStats, MMWR, 2023) Almost always the medical decision maker for the family (US Dept of Labor) And, …

Original article here by Ben Adams photo by TF-Images/Getty Images German Merck has set up a new collaboration with U.K. medtech company Calla Lily Clinical Care to work on its next-generation intravaginal drug delivery approach. London-based Calla Lily is working on several applications for its Callavid product, a tampon-shaped device that can be used as …

☀️ Excited to be heading to WHX Dubai 2026 to next week — and especially looking forward to showcasing our Callavid® drug delivery platform on stage as part of the Xcelerate Pitch Competition, within the dedicated Femtech & Women’s Health track. As the largest healthcare event in the region, WHX brings together a comprehensive mix …

Our co-founders Lara and Thang have been named in the annual ‘200 Trailblazing Leaders in Women’s Health and FemTech’ for the third year running. It’s a real who’s who of the influential leaders working to improve the access and quality of healthcare for women worldwide. We’re delighted at the recognition for Lara & Thang and of …

We’re delighted to share that our co-founder Lara was crowned the winner of the 🔥 Ignite Fire Pitch Competition, held during J.P. Morgan Week in San Francisco 🇺🇸 Ignite is a U.S. non-profit with a powerful mission: increasing the number of women leading and innovating the future of healthcare. The Ignite Fire Pitch represents the …

✨ Big congratulations to our board advisor Prof/Dr Annalisa Jenkins OBE on being recognised in the King’s New Year Honour’s List! Over more than 25 years, Annalisa has been an outstanding leader in the life sciences– building and guiding teams that have successfully taken programmes from early scientific discovery through clinical development, regulatory approval, and …

👏 CLCC is proud to share that we’ve successfully completed our ISO 9001 audit with *zero* major or minor non-conformities for the *third* year in a row. Quality has always been and will always be one of the core pillars of our company, and this result is a testament to the commitment, rigour, and consistency …

original article here: https://roivantsv.org/news/diversity-in-pharma-spotlight-naomi-aduroja Roivant Social Ventures (RSV) and Calla Lily Clinical Care have partnered to host the Global Access Fellowship Program, providing real-world drug development experience to talented PharmD students who are passionate about leveraging their career development to expand healthcare access to underserved patient groups. Calla Lily Clinical Care is transforming drug delivery …

original case study here: https://iuk-business-connect.org.uk/casestudy/innovate-uk-helps-calla-lily-bloom-in-womens-health/   Calla Lily Clinical Care is reshaping how vaginally administered drugs are delivered, starting with miscarriage prevention and fertility. With tailored business growth support from Innovate UK Business Growth, the London-based medical device company has secured £2.2 million in grant funding and more than £4.5 million in private investment, and …